Shigella and Enteroinvasive Escherichia Coli

I Belotserkovsky, PJ Sansonetti - Escherichia coli, a Versatile Pathogen, 2018 - Springer
Shigella and enteroinvasive Escherichia coli (EIEC) are gram-negative bacteria responsible
for bacillary dysentery (shigellosis) in humans, which is characterized by invasion and …

Prevalence of Multidrug-Resistant and Extended-Spectrum Beta-Lactamase-Producing Shigella Species in Asia: A Systematic Review and Meta-Analysis

MZ Salleh, NMN Nik Zuraina, K Hajissa, MI Ilias… - Antibiotics, 2022 - mdpi.com
Shigellosis remains one of the leading causes of morbidity and mortality worldwide and is
the second leading cause of diarrheal mortality among all age groups. However, the global …

Analysis of Shigella flexneri resistance, biofilm formation, and transcriptional profile in response to bile salts

KP Nickerson, RB Chanin, JR Sistrunk… - Infection and …, 2017 - Am Soc Microbiol
The Shigella species cause millions of cases of watery or bloody diarrhea each year, mostly
in children in developing countries. While many aspects of Shigella colonic cell invasion are …

[HTML][HTML] Antibiotic resistance trends for common bacterial aetiologies of childhood diarrhoea in low-and middle-income countries: A systematic review

R Neupane, M Bhathena, G Das, E Long… - Journal of Global …, 2023 - ncbi.nlm.nih.gov
Background Diarrhoea is the second most common cause of death among children under
the age of five worldwide. The World Health Organization (WHO) recommends treating …

Burden of Shigella in South Asia: a systematic review and meta-analysis

BA Muzembo, K Kitahara, D Mitra… - Journal of Travel …, 2023 - academic.oup.com
Background Shigella remains one of the most common causes of diarrhoea in South Asia.
Current estimates of the prevalence of Shigella are critical for guiding control measures. We …

Bacteriophage therapy testing against Shigella flexneri in a novel human intestinal organoid-derived infection model

A Llanos-Chea, RJ Citorik, KP Nickerson… - Journal of pediatric …, 2019 - journals.lww.com
Objective: Enteric bacterial pathogens cause diarrheal disease and mortality at significant
rates throughout the world, particularly in children younger than 5 years. Our ability to …

[HTML][HTML] Increasing antibiotic resistance in Shigella spp. from infected New York City residents, New York, USA

K Murray, V Reddy, JS Kornblum… - Emerging infectious …, 2017 - ncbi.nlm.nih.gov
Approximately 20% of Shigella isolates tested in New York City, New York, USA, during
2013–2015 displayed decreased azithromycin susceptibility. Case-patients were older and …

Clinical outcomes of drug-resistant shigellosis treated with azithromycin in Bangladesh

ER Houpt, T Ferdous, R Ara, M Ibrahim… - Clinical Infectious …, 2021 - academic.oup.com
Background Azithromycin is frequently used to treat shigellosis; however, clinical outcomes
are uncertain. Methods We performed an observational cohort study in Bangladesh of …

Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli …

M O'Ryan, R Vidal, F del Canto… - Human vaccines & …, 2015 - Taylor & Francis
In Part II we discuss the following bacterial pathogens: Shigella, Salmonella (non-typhoidal),
diarrheogenic E. coli (enterotoxigenic and enterohemorragic) and Campylobacter jejuni. In …

Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccine

KA Clarkson, KR Talaat, C Alaimo, P Martin… - …, 2021 - thelancet.com
Background Diarrheal diseases are a leading cause of global morbidity and mortality
affecting all ages, but especially children under the age of five in resource-limited settings …